Abstract
Utilizing glycosylated derivatives as a tag, we are able to explore novel counter-receptor of endogenous lectins or lectin-like molecules in vivo. We have established the standardized methodology including preparation of glycosylated derivatives and construction of a platform for tracing the molecules in vivo at first. Combined use of an aminooxy-terminated thiol derivative and a phosphorylcholine (PC) derivative provides quantum dots (QDs) with novel functions for the chemical ligation of ketone-functionalized compounds and the prevention of nonspecific protein adsorption concurrently. In order to track the derivatives in vivo, near-infrared (NIR) fluorescence imaging of QDs displaying various simple sugars (glyco-PC-QDs) after administration into the tail vein of the mouse can be performed. It has revealed that distinct long-term delocalization over 2 h can be observed depending on the species of glycans ligated to PC-QDs at least in the liver. Until today we have performed live animal imaging utilizing various kinds of sialyl glyco-PC-QDs. They are still retained stably in whole body after 2 h while they showed significantly different in vivo dynamics in the tissue distribution, suggesting that structure/sequence of the neighboring sugar residues in the individual sialyl oligosaccharides might influence the final organ-specific distribution, which should be equivalent to the distribution of sialic acid-recognizing lectins. Here we describe a standardized protocol using ligand-displayed PC-QDs for live cell/animal imaging by versatile NIR fluorescence photometry without influence of size-dependent accumulation/excretion pathway for nanoparticles (e.g., viruses) > 10 nm in hydrodynamic diameter by the liver.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Laughlin ST, Baskin JM, Amacher SL, Bertozzi CR (2008) In vivo imaging of membrane-associated glycans in developing zebrafish. Science 320:664–667
Andre S, Kozar T, Kojima S, Unverzagt C, Gabius H-J (2009) From structural to functional glycomics: core substitutions as molecular switches for shape and lectin affinity of N-glycans. Biol Chem 390:557–565
van Kasteren SI, Campbell SJ, Serres S, Anthony DC, Sibson NR, Davis BG (2009) Glyconanoparticles allow pre-symptomatic in vivo imaging of brain disease. Proc Natl Acad Sci U S A 106:18–23
Marradi M, Alcantara D, de la Fuente JM, Garcia-Martin ML, Cerdan S, Penades S (2009) Paramagnetic Gd-based gold glyconanoparticles as probes for MRI: tuning relaxivities with sugars. Chem Commun 26:3922–3924
Kikkeri R, Lepenies B, Adibekian A, Laurino P, Seeberger PH (2009) In vitro imaging and in vivo liver targeting with carbohydrate capped quantum dots. J Am Chem Soc 131:2110–2112
Tanaka K, Siwu ER, Minami K, Hasegawa K, Nozaki S, Kanayama Y, Koyama K, Chen WC, Paulson JC, Watanabe Y, Fukase K (2010) Noninvasive imaging of dendrimer-type N-glycan clusters: in vivo dynamics dependence on oligosaccharide structure. Angew Chem Int Ed 49:8195–8200
Lee YC (1992) Biochemistry of carbohydrate-protein interaction. FASEB J 6:3193–3200
Lee YC, Lee RT (1995) Carbohydrate-protein interactions: Basis of glycobiology. Acc Chem Res 28:321–327
Mammen M, Choi SK, Whitesides GM (1998) Polyvalent interactions in biological systems: implications for design and use of multivalent ligands and inhibitors. Angew Chem Int Ed 37:2754–2794
Lundquist JJ, Toone EJ (2002) The cluster glycoside effect. Chem Rev 102:555–578
de la Fuente JM, Eaton P, Barrientos AG, Rojas TC, Rojo J, Canada J, Fernandez A, Penades S (2001) Gold glyconanoparticles as water-soluble polyvalent models to study carbohydrate interactions. Angew Chem Int Ed 40:2257–2261
Katz E, Willner I (2004) Integrated nanoparticle-biomolecule hybrid systems: synthesis, properties, and applications. Angew Chem Int Ed 43:6042–6108
Marradi M, Martin-Lomas M, Penades S (2010) Glyconanoparticles polyvalent tools to study carbohydrate-based interactions. Adv Carbohydr Chem Biochem 64:211–290
Reed MA, Randall JN, Aggarwal RJ, Matyi RJ, Moore TM, Wetsel AE (1988) Observation of discrete electronic states in a zero-dimensional semiconductor nanostructure. Phys Rev Lett 60:535–537
Rossetti R, Nakahara S, Brus LE (1983) Quantum size effects in the redox potentials, resonance Raman spectra, and electronic spectra of CdS crystallites in aqueous solution. J Chem Phys 79:1086–1088
Gleiter H (1992) Nanostructured materials. Adv Mater 4:474–481
Alivisatos AP (1996) Semiconductor clusters, nanocrystals, and quantum dots. Science 271:933–937
Medintz IL, Uyeda HT, Goldman ER, Mattoussi H (2005) Quantum dot bioconjugates for imaging, labelling and sensing. Nat Mater 4:435–446
Nagahori N, Abe M, Nishimura S-I (2009) Structural and functional glycosphingolipidomics by glycoblotting with an aminooxy-functionalized gold nanoparticle. Biochemistry 48:583–594
Ohyanagi T, Nagahori N, Shimawaki K, Hinou H, Yamashita T, Sasaki A, Jin T, Iwanaga T, Kinjo M, Nishimura S-I (2011) Importance of sialic acid residues illuminated by live animal imaging using phosphorylcholine self-assembled monolayer-coated quantum dots. J Am Chem Soc 133:12507–12517
Shimaoka H, Kuramoto H, Furukawa J-I, Miura Y, Kurogochi M, Kita Y, Hinou H, Shinohara Y, Nishimura S-I (2007) One-pot solid-phase glycoblotting and probing by transoximization for high-throughput glycomics and glycoproteomics. Chem Eur J 13:1664–1673
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this protocol
Cite this protocol
Amano, M., Hinou, H., Miyoshi, R., Nishimura, SI. (2014). Potential Usage for In Vivo Lectin Screening in Live Animals Utilizing Cell Surface Mimetic Glyco-nanoparticles, Phosphorylcholine-Coated Quantum Dots (PC-QDs). In: Hirabayashi, J. (eds) Lectins. Methods in Molecular Biology, vol 1200. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-1292-6_31
Download citation
DOI: https://doi.org/10.1007/978-1-4939-1292-6_31
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-1291-9
Online ISBN: 978-1-4939-1292-6
eBook Packages: Springer Protocols